The life science industry is changing. At the CED Life Science Conference 2013, we address the challenges that companies will face in 2013 and beyond, with a particular eye towards the interaction of startups, pharmaceutical companies and healthcare providers and the impact of the Affordable Care Act.
Join more than 1,000 of your peers and participate in partnering meetings throughout the CED Life Science Conference 2013. These sessions will provide you valuable opportunities to discuss potential licensing deals with investors, corporate groups, and tech transfer officers
The CED Life Science Conference 2013 also showcases the innovation occurring at biopharma and medtech startups, with an understanding of the change, challenges and opportunities within the industry.
Print to Page
